STOCK TITAN

PMV Pharmaceuticals, Inc. - $PMVP STOCK NEWS

Welcome to our dedicated page for PMV Pharmaceuticals news (Ticker: $PMVP), a resource for investors and traders seeking the latest updates and insights on PMV Pharmaceuticals stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PMV Pharmaceuticals's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PMV Pharmaceuticals's position in the market.

Rhea-AI Summary
PMV Pharmaceuticals to present updated Phase 1 data of PC14586 at AACR-NCI-EORTC Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
conferences clinical trial
-
Rhea-AI Summary
PMV Pharmaceuticals reports progress in PYNNACLE study of PC14586, alignment with FDA on Phase 2 dose, and appointment of Dr. Masha Poyurovsky as VP of Biology. Q2 2023 financial results show $218.8M in cash, net loss of $36.6M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.69%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.49%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.33%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.15%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.15%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.02%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.31%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.06%
Tags
PMV Pharmaceuticals, Inc.

Nasdaq:PMVP

PMVP Rankings

PMVP Stock Data

104.94M
41.01M
2.95%
99.55%
5.06%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
PRINCETON

About PMVP

pmv pharmaceuticals, inc., a precision oncology company, discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. its lead product candidate is pc14586, a small molecule that corrects and restores p53 function. the company also develops product candidates for p53 r273h hotspot mutation and other p53 hotspot mutations. pmv pharmaceuticals, inc. was formerly known as pj pharmaceuticals, inc. and changed to in july 2013. the company was founded in 2013 and is headquartered in cranbury, new jersey.